Home » Topics » BioWorld Science

BioWorld Science
RSS

Hamlet and Neurochase partner to develop novel technology to deliver Alpha-1H for CNS tumors

June 14, 2022

Evotec and Janssen Pharmaceutica establish drug discovery collaboration

June 14, 2022

Discovery of novel cathepsin C inhibitor with anti-inflammatory activity in vivo

June 14, 2022

Alpha Cognition announces discovery of GEM combinations ALPHA-0702 and ALPHA-0802

June 14, 2022

NXP-900 shows tumor growth inhibition and survival benefit in mouse model of group 4 medulloblastoma

June 14, 2022

Omadacycline, a promising treatment approach for chlamydial infections

June 14, 2022

Novel neurodevelopmental disorder associated with germline variants in FBXW7

June 14, 2022

Chinese researchers disclose cardiac myosin inhibitors

June 14, 2022

DA-1726 shows efficacy in diet-induced NASH mouse model

June 14, 2022

Fochon Pharmaceuticals identifies new BTK inhibitors

June 14, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...